PURE Bioscience Valuation Multiples
Discover revenue and EBITDA valuation multiples for PURE Bioscience.
PURE Bioscience Overview
About PURE Bioscience
PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, and products preserved with SDC and SDC as a raw material ingredient for manufacturing use. The company generates revenue from the sale of its antimicrobial products.
Founded
1992
HQ
Employees
12
Website
Financials (FY)
EV
$16M
Valuation Multiples
Start free trial
PURE Bioscience Financials
PURE Bioscience reported last fiscal year revenue of $2M and negative EBITDA of ($2M).
In the same fiscal year, PURE Bioscience generated $1M in gross profit, ($2M) in EBITDA losses, and had net loss of ($2M).
PURE Bioscience P&L
In the most recent fiscal year, PURE Bioscience reported revenue of $2M and EBITDA of ($2M).
PURE Bioscience is unprofitable as of last fiscal year, with gross margin of 59%, EBITDA margin of (95%), and net margin of (109%).
Financial data powered by Morningstar, Inc.
PURE Bioscience Stock Performance
PURE Bioscience has current market cap of $10M, and enterprise value of $16M.
PURE Bioscience's stock price is $0.08.
PURE Bioscience has an EPS (earnings per share) of $-0.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $16M | $10M | 28.2% | - | - | - | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPURE Bioscience Valuation Multiples
PURE Bioscience trades at 7.2x EV/Revenue multiple, and (7.6x) EV/EBITDA.
PURE Bioscience Financial Valuation Multiples
As of August 14, 2026, PURE Bioscience has market cap of $10M and EV of $16M.
PURE Bioscience has a P/E ratio of (4.3x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified PURE Bioscience Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
PURE Bioscience Margins & Growth Rates
In the most recent fiscal year, PURE Bioscience reported gross margin of 59%, EBITDA margin of (95%), and net margin of (109%).
PURE Bioscience Margins
PURE Bioscience Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
PURE Bioscience Operational KPIs
PURE Bioscience's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.3M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
PURE Bioscience Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all PURE Bioscience competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout PURE Bioscience
| When was PURE Bioscience founded? | PURE Bioscience was founded in 1992. |
| Where is PURE Bioscience headquartered? | PURE Bioscience is headquartered in United States. |
| How many employees does PURE Bioscience have? | As of today, PURE Bioscience has over 12 employees. |
| Is PURE Bioscience publicly listed? | Yes, PURE Bioscience is a public company listed on OTCM. |
| What is the stock symbol of PURE Bioscience? | PURE Bioscience trades under PURE ticker. |
| When did PURE Bioscience go public? | PURE Bioscience went public in 1996. |
| Who are competitors of PURE Bioscience? | PURE Bioscience main competitors include |
| What is the current market cap of PURE Bioscience? | PURE Bioscience's current market cap is $10M. |
| What is the current revenue of PURE Bioscience? | PURE Bioscience's last fiscal year revenue is $2M. |
| What is the current EV/Revenue multiple of PURE Bioscience? | Current revenue multiple of PURE Bioscience is 7.2x. |
| Is PURE Bioscience profitable? | No, PURE Bioscience is not profitable. |
| How many companies PURE Bioscience has acquired to date? | PURE Bioscience hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies PURE Bioscience has invested to date? | PURE Bioscience hasn't invested in any companies yet (or none have been disclosed publicly). |
Lists including PURE Bioscience
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.